Trials / Conditions / FLT3 Gene Mutation
FLT3 Gene Mutation
4 registered clinical trials studyying FLT3 Gene Mutation — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia NCT06667973 | Gruppo Italiano Malattie EMatologiche dell'Adulto | Phase 2 |
| Recruiting | The Efficacy of Triple Regimen in Newly Diagnosed AML Patients With FLT3 Mutation NCT06561880 | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 / Phase 2 |
| Active Not Recruiting | AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission NCT04062266 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia NCT01253070 | National Cancer Institute (NCI) | Phase 2 |